Gilead and LEO Pharma partner to develop programs for inflammatory diseases By Reuters
(Reuters) - Gilead Sciences (NASDAQ:) said on Saturday it has partnered with Denmark's LEO Pharma to develop programs to treat ...
Tag: Diseases
Revealing the Diagnostic Landscape: Assessing AI and Human Performance in the Long Tail of Rare Diseases
Using large amounts of labeled data, supervised machine learning algorithms have outperformed human experts in various tasks, raising concerns about ...
Recommended.
